Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a wide range of financing solutions and support services for businesses at various stages of their development. Established in 1980 and based in Maisons-Alfort, France, the company offers medium to long-term loans, export insurance, real estate and equipment leasing, and working capital loans. Bpifrance also invests in startups, small and medium-sized enterprises (SMEs), and mid-cap companies through direct investments and fund management activities. Additionally, it provides consulting services for executives and training for CEOs, aiming to facilitate innovation and growth. Bpifrance was formed from the merger of several entities in July 2013, including OSEO, CDC Entreprises, and FSI, to enhance its role in supporting the financing of the French economy.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Cross-Functional Investments Venture Capital

Elyssa Maufras du Châtellier

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Sofia Dahoune

Associate

Vanessa Giraud

Managing Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Hortense Jacon

Investment Associate

Veronique Jacq

Head of Digital Venture team

So-Yeon Koo

Senior Investment Manager

Eric Lefebvre

Director

Arnaud Legardeur

Investment Director

Serge Mesguich

Director

Louis Molis

Investment Director

Adrien Neel

Investment Director

Gilles Schang

Deputy Director

Tuan Tran

Investment Director / VC

Past deals in Lyon

Ludocare

Seed Round in 2022
Ludocare focuses on developing therapeutic robots that assist patients with chronic diseases and their families. The company's innovative devices are designed to complement traditional drug treatments by providing personalized support that enhances treatment efficiency. By empowering patients, especially children, Ludocare aims to improve therapeutic compliance both quantitatively and qualitatively. This approach facilitates better disease management and helps stabilize essential treatments, ultimately contributing to improved autonomy and quality of life for patients and their families.

Osivax

Grant in 2022
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.

Handivoyage

Series A in 2022
Handivoyage SAS operates an online travel booking platform specifically designed for individuals with disabilities. Founded in 2016 and based in Lyon, France, the company offers a variety of services, including holiday and hotel bookings, as well as access to medical equipment, medical aid, and adapted transportation. Committed to continuous improvement, Handivoyage actively collects customer feedback through comprehensive questionnaires following each stay, allowing them to enhance their service quality. This focus on user experience is central to their mission of providing accessible travel options for people with disabilities.

Konect

Pre Seed Round in 2022
Konect is a software-as-a-service (SaaS) platform designed to serve the gaming community by enabling users to create personalized websites. The platform allows gaming enthusiasts to build their online profiles, connect with other gamers, and discover opportunities. Users can centralize all their online content, making it easy to share with their community. This streamlined approach not only fosters connections among gamers but also simplifies the process of sharing content and engaging with a wider audience.

Susu

Debt Financing in 2022
Susu is a health tech company focused on providing accessible and affordable healthcare services to families in the African diaspora. The company offers a comprehensive range of services, including preventive care, medical treatments, chronic disease management, and authentic medications. By delivering health bundle services through its platform, Susu aims to facilitate long-term health support for patients, ensuring effective monitoring of various health conditions such as pregnancy and chronic diseases. This approach enables individuals to access quality healthcare services and insurance, promoting overall well-being within the communities it serves.

Susu

Grant in 2022
Susu is a health tech company focused on providing accessible and affordable healthcare services to families in the African diaspora. The company offers a comprehensive range of services, including preventive care, medical treatments, chronic disease management, and authentic medications. By delivering health bundle services through its platform, Susu aims to facilitate long-term health support for patients, ensuring effective monitoring of various health conditions such as pregnancy and chronic diseases. This approach enables individuals to access quality healthcare services and insurance, promoting overall well-being within the communities it serves.

Groupe SFC

Venture Round in 2022
• A team of 200 employees including 18 associates, providing daily guidance to more than 5000 clients • 9 locations in France • Our policy is geared towards quality and customer satisfaction • Understanding of technology which guarantees the use of high-performance and specialised solutions • Experts to drive forward your performance, at all stages of your company’s life • In 2012, turnover of close to €14.5m

MyFit Solutions

Funding Round in 2021
MyFit Solutions develops SaaS entreprise software that provides 3D scanning solutions to make product size recommendation or tailor-made products.

Rushmix

Venture Round in 2021
Rushmix SAS, founded in 2018 and located in Lyon, France, operates a platform that enables users to transform their photos and videos into short films within 72 hours. The service caters to a variety of needs, offering specialized video formats such as sports films, wedding films, family films, travel movies, and custom film options. By providing an accessible and efficient way for consumers and businesses to create personalized movies, Rushmix enhances the video editing experience.

Sis ID

Series A in 2021
The My Sis ID platform is the first community of financial departments that preserves transfer fraud by pooling banking identities and their control costs.

1Kubator

Venture Round in 2021
1Kubator SAS is an Accelerator specializing in French startups operating in all type of sectors, with a strong focus on information technology. The firm takes 10% equity stake and provides a grant of €0.025 per project to cover the cost of the incubation program, which has a duration of 10 months. The firm aims to finance and support 300 seed projects per year. It prefers to partner with first-time entrepreneurs, among others from schools and universities. It seeks to hold its companies in portfolio for at least 5 years. In addition to its mentoring programs, the firm has partnerships with a network of accelerators and offers its support to the raising of seed funds. 1Kubator SAS was founded in 2015 and is headquartered in Lyon, France with additional offices in Bordeaux, Nantes, Rennes, Lille, Strasbourg and one office in China.

erytech

Post in 2020
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company based in Lyon, France, founded in 2004. The company specializes in the development of red blood cell-based therapeutics aimed at treating cancer and orphan diseases. Its lead product candidate, eryaspase, is currently undergoing Phase III clinical trials for second-line pancreatic cancer and Phase II trials for triple-negative breast cancer. Additionally, ERYTECH is developing erymethionase, a preclinical candidate targeting methionine-dependent cancers, which consists of methionine-gamma-lyase encapsulated in red blood cells. The company collaborates with research institutions such as the Fox Chase Cancer Center and Queen’s University of Canada to enhance the preclinical development of its products for conditions like homocystinuria and arginase-1 deficiency, respectively. Through its innovative approach to encapsulating therapeutic molecules, ERYTECH Pharma aims to improve the efficacy and safety of its treatments.

Osivax

Grant in 2020
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.

B-Hive Engineering

Venture Round in 2020
B-Hive Engineering is an engineering and operational consulting firm based in Mulhouse, France, with additional operations in Lyon, Paris, and Montréal, Canada. Founded in 2017, the company provides a range of technical assistance, support, and project management services across various sectors, including chemistry, petrochemistry, energy, food, pharmaceuticals, and biotechnology. It also caters to the automotive, rail, aeronautics, infrastructure, and civil engineering sectors, covering areas such as urban planning, structural engineering, tunnels, and high-speed rail lines. B-Hive Engineering focuses on delivering tailored solutions to meet the specific needs of its clients in these diverse industries.

Nyctale

Pre Seed Round in 2020
Nyctale SAS, founded in 2018 and based in Paris, France, specializes in developing analytics tools focused on blockchain technology and distributed ledger systems. The company offers solutions for analyzing token usage, measuring value, and managing financial flows within new transactional networks. Nyctale provides business intelligence services aimed at entrepreneurs, enabling them to assess performance and conduct due diligence. Additionally, it supports public and private financial institutions with risk assessment, product development beta-testing, and investment strategies. Through its big data and AI solutions, Nyctale also works on rationalizing the token economy and offers comprehensive blockchain monitoring services.

Fab'entech

Series C in 2020
Founded in 2009 and based in Lyon, France, Fab’entech is a biopharmaceutical company that specializes in developing and commercializing innovative passive immunotherapeutic solutions. The company focuses on specific polyclonal immunoglobulins [F(ab’)₂] aimed at treating emerging infectious diseases and certain drug intoxications. By utilizing highly purified fragments of horse-specific polyclonal immunoglobulins, Fab’entech provides healthcare institutions with effective therapeutic options for emergency situations. As a member of the LyonBiopôle cluster, the company contributes to advancements in medical technology and immunotherapy.

Deeplink Medical

Venture Round in 2019
Deeplink-Medical is the answer to the real needs of the field apprehended by the founding medical team and the inadequacy of available telemedicine IT solutions. The design of innovative tools led by an experienced medical team, coupled with a framework of practices (support, training, medical protocol, activity monitoring) ensure the success of a telemedicine project and the optimization of the management patients.

Laclarée

Seed Round in 2019
Laclarée Vision, founded in 2016 and based in Lyon, France, specializes in developing adaptive eyeglasses designed to correct presbyopia. The company employs patented fluid technology to create variable-focus lenses that automatically adjust to the viewer's distance, providing clear vision at all ranges. This innovation targets individuals aged 45 and older who are dissatisfied with traditional solutions, such as progressive lenses or multiple pairs of glasses. By integrating advanced adaptive lens technology, Laclarée aims to enhance the visual experience for those with additional refractive errors like astigmatism, myopia, or hyperopia.

Ryax Technologies

Venture Round in 2019
Ryax Technologies SAS is a French firm established in 2017 that specializes in developing infrastructure software for the Internet of Things (IoT). The company focuses on resource and compute management across hybrid infrastructures, including edge, fog, and cloud environments. Ryax's software facilitates complex computations of live data, optimizing application execution while ensuring robust security and data privacy. The technology is particularly tailored for sectors such as the Industrial Internet and Smart Cities, leveraging over a decade of expertise in high-performance computing. By employing advanced resource allocation and deployment techniques, Ryax enables efficient use of computational resources based on specific application requirements. The software also supports encrypted communications and data privacy management, allowing clients to control data transport. Additionally, it streamlines stream processing across the entire infrastructure and simplifies application development through an adaptable software development kit (SDK) compatible with various programming languages.

FinKey

Seed Round in 2019
FinKey SAS, founded in 2017 and based in Lyon, France, is a digital platform that assists start-ups and small businesses in identifying suitable financing options for their projects. The company offers a comprehensive database of public and private financing sources, streamlining the process of securing funding. In addition to its core financing services, FinKey also provides advisory services related to mergers, acquisitions, and leveraged buyout transactions, primarily serving clients in the information technology, software, cloud technology, and SaaS sectors.

Addev Materials

Private Equity Round in 2019
Addev Materials specializes in the transformation of high-performance materials.

Nukeygara

Venture Round in 2018
SAS Nukeygara is a company based in Lyon, France, specializing in the design and development of 3D animation software for the video game industry, known as Akeytsu. Launched in 2014, Akeytsu is dedicated to character rigging and animation, providing an artistic-oriented approach that distinguishes it from traditional broad-based 3D solutions. The software emphasizes simplicity, speed, and ergonomics, catering to professional animators, beginners, and students alike. Akeytsu integrates seamlessly with the Filmbox (FBX) production pipeline, making it a valuable tool for indie game developers, media and entertainment content creators, and professional studios. The company's focus on user experience ensures that animators can efficiently access all necessary tools for their creative processes.

E-attract

Funding Round in 2018
E-attract, founded in 2017 and based in Feyzin, France, specializes in developing software and data solutions focused on residential mobility. The company assists both public and private entities, including regional governments, municipalities, and sectors such as real estate, energy, transport, and banking, in designing and distributing services that align with citizen expectations. E-attract aims to enhance the quality of life for citizens by facilitating informed choices about their living environments. Their flagship application, vivrou.com, serves as a resource for individuals seeking the best places to live, providing them with relevant information tailored to their specific needs and preferences. By leveraging data, E-attract endeavors to foster a more personalized relationship between citizens and their territories, ultimately promoting smarter, user-centric communities.

Mon Chasseur Immo

Venture Round in 2018
Mon Chasseur Immo is a real estate agency based in Montpellier, France, with additional offices in Paris, Lyon, and Bordeaux. Founded in 2012 and rebranded in 2018, the agency specializes in facilitating the search and acquisition of residential properties, including apartments and houses, across various cities such as Paris, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Strasbourg, Toulouse, and Aix-en-Provence. The company provides a range of services, including targeted property visits, personalized support throughout the buying process, and assistance with real estate tax exemptions. Additionally, Mon Chasseur Immo offers a property search platform that allows users, including expatriates, to communicate directly with property owners, organize visits, and negotiate prices, streamlining the real estate transaction process.

ENYO Pharma

Series B in 2018
ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, focused on drug discovery and development for acute and chronic viral infections. Founded in 2014 by a group of scientists from the Infectiology Research Center, the company has established a unique platform to identify intracellular therapeutic targets and molecules, particularly for human pathogens. ENYO Pharma is developing treatments for significant viral infections, with ongoing programs targeting chronic hepatitis B and severe influenza. Its lead compound, EYP001, is designed to modulate FXR and reduce viral replication, while EYP002 is currently undergoing preclinical studies. The company aims to advance its pipeline into Phase II clinical trials and collaborates closely with research institutions to leverage innovative therapeutic strategies. ENYO Pharma is committed to addressing unmet medical needs in infectious and metabolic diseases, positioning itself as a leader in antiviral therapies.

Handivoyage

Seed Round in 2018
Handivoyage SAS operates an online travel booking platform specifically designed for individuals with disabilities. Founded in 2016 and based in Lyon, France, the company offers a variety of services, including holiday and hotel bookings, as well as access to medical equipment, medical aid, and adapted transportation. Committed to continuous improvement, Handivoyage actively collects customer feedback through comprehensive questionnaires following each stay, allowing them to enhance their service quality. This focus on user experience is central to their mission of providing accessible travel options for people with disabilities.

Fill Up Media

Venture Round in 2017
Fill Up Média is an innovative advertising agency, offering a new communication medium: a screen built into the payment automat of the fuel dispensing pumps. This new medium allows stationary diffusion of multimedia advertising content, targeted and enriched during fueling. The company was founded in 2011 and headquartered in Lyon, Rhone-Alpes, France.

VeriCampus

Grant in 2017
VeriCampus specializes in enhancing student support for colleges and universities through the use of artificial intelligence. The company develops AI-powered chatbots, known as 'Campus Assistants,' which are designed to embody the character and knowledge of the institution. These chatbots assist students in navigating their college experience more effectively. Additionally, VeriCampus offers a messaging platform that aims to make education more accessible and affordable. This platform provides educational institutions with the necessary products, services, and information to facilitate student success and improve engagement across various aspects of the educational process. By focusing on personalized service at a lower cost, VeriCampus empowers schools to enhance the overall student experience.

Nightswapping

Series B in 2016
Nightswapping is a peer-to-peer accommodation exchange platform that facilitates free stays among its community of over 150,000 members. By allowing users to swap nights in each other's homes, the platform enables travelers to experience authentic local living without the involvement of money, thereby avoiding legal complications associated with traditional rentals. Members can either convert their nights into real money or use them to travel for free, with options available in over 160 countries. Nightswapping also offers personalized travel suggestions for those uncertain about their destination, promoting unique and unexpected travel experiences.

New Nomads

Funding Round in 2016
New Nomads is a the specialist of innovative youth hostels. Founded in 2013 by Charlotte Bollard, Julien Routil and Pierric Soum, three associates with complementary profiles (architecture, strategy & marketing, finance), New Nomads designs and manages new generation hostels, more design, more comfortable and always at very competitive rates

Wizaplace

Venture Round in 2016
Wizaplace is a software as a service platform based in Lyon, France, that specializes in the creation and management of online marketplaces. Established in 2012 and officially launched in 2015, the platform supports various marketplace models, including B2C, B2B, and C2C, as well as tailored service marketplaces. It features an integrated environment with approximately 70 modules that facilitate the development of diverse e-commerce solutions, e-services, crowdfunding initiatives, and collaborative platforms. The company was co-founded and is run by Eric and Cécile Alessandri, and as of January 2017, it had a team of around 20 employees.

Geolid

Series C in 2015
Geolid is a web advertising platform aimed at supporting local businesses in France by enhancing their communication practices. The company provides tools for geolocalized advertising and search optimization, allowing major brands to digitize their networks and maintain a consistent online presence. This approach enables franchisees and small businesses to efficiently engage with their customers through a unified platform, ultimately boosting local business visibility and effectiveness. Geolid focuses on transforming how businesses communicate with consumers, ensuring that they can effectively reach their target audience in a competitive digital landscape.

Synchrone

Private Equity Round in 2015
Synchrone provides its key account clients with high-level expert assessments on complex technological issues. Preferred partner of major banking and financial institutions and insurance companies, Synchrone offers tailor made solutions combining business skills, methodological know-how and technological expertise. It assists its clients in their strategic approaches: Financial/Banking, Cloud/Big data, Digital Intelligence, Expertise Center.

Genymobile

Series A in 2015
Genymobile, founded in 2011 and headquartered in Paris with additional offices in Lyon and San Francisco, specializes in Android-based technologies that enhance application development and testing. Its flagship product, the Genymotion Desktop Android Emulator, boasts over 8 million users globally and is recognized as a leading solution for Android application development and testing. The company's cloud offering, Genymotion Cloud, is available as both Software as a Service (SaaS) and Platform as a Service (PaaS) on major cloud platforms such as AWS, GCP, Alibaba Cloud, and Microsoft Azure. This cloud solution is designed to help Android app developers automate their testing processes and accelerate time-to-market for their applications. Genymobile serves a diverse clientele, including prominent tech companies like Facebook, Twitter, Square, and Microsoft, providing tools that ensure compatibility across various electronic devices and enhance mobility connections.

DOZ

Seed Round in 2014
DOZ Marketing Software helps create an organic marketing campaign and to launch a customized timeline of tasks needed to achieve marketing goals.DOZ has vetted marketing professionals from around the world. DOZ automatically assigns the right experts to every task on custom, marketing campaign.DOZ helps websites to run more effective online marketing campaigns by managing natives industry experts and marketing professionals.

Nightswapping

Seed Round in 2014
Nightswapping is a peer-to-peer accommodation exchange platform that facilitates free stays among its community of over 150,000 members. By allowing users to swap nights in each other's homes, the platform enables travelers to experience authentic local living without the involvement of money, thereby avoiding legal complications associated with traditional rentals. Members can either convert their nights into real money or use them to travel for free, with options available in over 160 countries. Nightswapping also offers personalized travel suggestions for those uncertain about their destination, promoting unique and unexpected travel experiences.

Poxel

Series B in 2014
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.

Geolid

Series B in 2013
Geolid is a web advertising platform aimed at supporting local businesses in France by enhancing their communication practices. The company provides tools for geolocalized advertising and search optimization, allowing major brands to digitize their networks and maintain a consistent online presence. This approach enables franchisees and small businesses to efficiently engage with their customers through a unified platform, ultimately boosting local business visibility and effectiveness. Geolid focuses on transforming how businesses communicate with consumers, ensuring that they can effectively reach their target audience in a competitive digital landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.